Reuter U, et al. Long-term efficacy and safety of erenumab: Results from 64 weeks of the LIBERTY study. IHC-OR-006. IHC 2019 5-8 sept. Dublin, Ierland.
Podcast: Stem cell therapy for PD - A new era for managing Parkinson’s disease?
dec 2023 | Bewegingsstoornissen